RecruitingPhase 3NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sponsor: Sanofi
Coral Springs, FL · Miami, FL · +19 more sites
4 recruiting sickle cell disease studies with a site in Miami, FL.
Sponsor: Sanofi
Coral Springs, FL · Miami, FL · +19 more sites
Sponsor: Novartis Pharmaceuticals
Miami, FL · +8 more sites
Sponsor: Novo Nordisk A/S
Hollywood, FL · Miami, FL · +37 more sites
Sponsor: American Thrombosis and Hemostasis Network
Gainesville, FL · Miami, FL · +73 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.